Barlean's Brevail 30 Caps
There are a limited number of products on the market that adequately address breast health. Barlean's Brevail is a women's nutritional supplement that takes a proactive approach to breast health and hormone regulation. Brevail is a plant extract that helps women maintain orderly cell division of healthy breast tissue. If you are concerned about breast health, Brevail can put your mind at ease.
Brevail is a once-daily pill, containing a blend of ingredients that increase lignan concentration in the body. If you are experiencing PMS or menopausal symptoms, Brevail can also help you alleviate the discomfort. This really is a dual purpose product intended to help women feel comfortable.
Barlean's Brevail 30 Caps Benefits
• Proactive Supplement
• Maintains Healthy Breast Tissue
• Increases Lignan Concentrations
• Relieves PMS & Menopause Symptoms
One capsule per day takenwith juice or water, with or without meals.
Barlean's Brevail Supplement Facts & Ingredients
Serving Size: 1 Capsule
Servings Per Container: 30
Vitamin D3 (as cholecalciferol) 400IU
Secoisolariciresinol Diglycoside 50mg
*Percent Daily Values are based on a 2,000 calorie diet.
*Daily Value Not Established
Potato maltodextrin, hypromellose, rice flour, magnesium stearate and titanium dioxide.
Not recommended for pregnant, lactating, this attempting to conceive or adolescent females.
Setchell KD, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, Heubi JE. Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct. 2014;5(3):491–501. doi:10.1039/c3fo60402k
Kezimana P, Dmitriev AA, Kudryavtseva AV, Romanova EV, Melnikova NV. Secoisolariciresinol Diglucoside of Flaxseed and Its Metabolites: Biosynthesis and Potential for Nutraceuticals. Front Genet. 2018;9:641. Published 2018 Dec 12. doi:10.3389/fgene.2018.00641
Imran M, Ahmad N, Anjum FM, et al. Potential protective properties of flax lignan secoisolariciresinol diglucoside. Nutr J. 2015;14:71. Published 2015 Jul 28. doi:10.1186/s12937-015-0059-3